March 1, 2017 / 12:14 PM / in 8 months

BRIEF-Wockhardt Ltd gets USFDA warning letter for co's stepdown unit

March 1 (Reuters) - Wockhardt Ltd:

* Says USFDA issued a warning letter to Morton Grove Pharmaceuticals Inc., USA, a stepdown subsidiary of company

* Says current portfolio of company will continue to be made available in market

* Says new approvals will be withheld till resolution

* Says company has already initiated appropriate measures since last several months to address the issues raised by USFDA Source text: bit.ly/2lbXlGX Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below